This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Pozzatti, R Articles by Khoury, G Search for Related Content PubMed PubMed Citation Articles by Pozzatti, R Articles by Khoury, G

 Previous Article

Mol Cell Biol. 1988 July; 8(7): 2984-2988

The E1a gene of adenovirus type 2 reduces the metastatic potential of ras-transformed rat embryo cells.

Laboratory of Molecular Virology, National Cancer Institute, Bethesda, Maryland 20892.

ABSTRACT

We have previously demonstrated that second-passage rat embryo cells transformed by the ras oncogene alone are both tumorigenic and highly metastatic when injected into nude mice. In contrast, rat embryo cells cotransformed with the ras oncogene and the adenovirus type 2 (Ad2) E1a gene are tumorigenic but either fail to metastasize or exhibit a very low metastatic potential. In this report, we demonstrate that transfection of the Ad2 E1a gene into four independent ras-transformed rat embryo cell lines results in a dramatic reduction in metastatic potential relative to that of the parental cell line. Transfection of cDNAs for the 12S and 13S E1a transcripts showed that the 12S cDNA was highly effective in reducing the metastatic potential of ras-transformed cell lines, while the 13S cDNA showed an effect in only one of the two cell lines tested. This effect is specific to the Ad2 E1a gene, since ras-transformed cell lines expressing the Ad12 E1a gene maintained their high metastatic potential. We hypothesize that the Ad2 E1a gene may regulate the expression of one or more cellular genes that contribute to the metastatic phenotype.

This article has been cited by other articles:

• Rau, K-M, Kang, H-Y, Cha, T-L, Miller, S A, Hung, M-C (2005). The mechanisms and managements of hormone-therapy resistance in breast and prostate cancers. Endocr Relat Cancer 12: 511-532 [Abstract] [Full Text]  
• Wong, C. W., Lee, A., Shientag, L., Yu, J., Dong, Y., Kao, G., Al-Mehdi, A. B., Bernhard, E. J., Muschel, R. J. (2001). Apoptosis: An Early Event in Metastatic Inefficiency. Cancer Res. 61: 333-338 [Abstract] [Full Text]  
• Ueno, N. T., Bartholomeusz, C., Herrmann, J. L., Estrov, Z., Shao, R., Andreeff, M., Price, J., Paul, R. W., Anklesaria, P., Yu, D., Hung, M.-C. (2000). E1A-mediated Paclitaxel Sensitization in HER-2/neu-overexpressing Ovarian Cancer SKOV3.ip1 through Apoptosis Involving the Caspase-3 Pathway. Clin. Cancer Res. 6: 250-259 [Abstract] [Full Text]  
• Schaeper, U., Subramanian, T., Lim, L., Boyd, J. M., Chinnadurai, G. (1998). Interaction between a Cellular Protein That Binds to the C-terminal Region of Adenovirus E1A (CtBP) and a Novel Cellular Protein Is Disrupted by E1A through a Conserved PLDLS Motif. J. Biol. Chem. 273: 8549-8552 [Abstract] [Full Text]